We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$813M
AUM Growth
+$43.5M
Cap. Flow
-$1.72M
Cap. Flow %
-0.21%
Top 10 Hldgs %
20.71%
Holding
251
New
10
Increased
63
Reduced
107
Closed
7

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$2.9M
2
AL
Air Lease Corp
AL
+$2.05M
3
IQV icon
IQVIA
IQV
+$1.92M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.89M
5
GE icon
GE Aerospace
GE
+$1.74M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.64M
2
MIDD icon
Middleby
MIDD
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.58M
4
ROK icon
Rockwell Automation
ROK
+$1.34M
5
AAPL icon
Apple
AAPL
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Industrials 14.02%
3 Technology 13.29%
4 Consumer Staples 10.45%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
76
JPMorgan Chase
JPM
$959B
$3.33M 0.41%
37,875
-120
-0.3% -$10.6K
RPM icon
77
RPM International
RPM
$14.7B
$3.24M 0.4%
58,798
+525
+0.9% +$28K
EOG icon
78
EOG Resources
EOG
$73.7B
$3.11M 0.38%
31,902
+7,722
+32% +$770K
DD
79
DELISTED
Du Pont De Nemours E I
DD
$3.08M 0.38%
38,409
-490
-1% -$38K
TMO icon
80
Thermo Fisher Scientific
TMO
$212B
$3.07M 0.38%
19,980
+1,115
+6% +$170K
D icon
81
Dominion Energy
D
$60.5B
$3.06M 0.38%
39,495
– –
VEU icon
82
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
$2.95M 0.36%
61,652
+43
+0.1% +$2K
MON
83
DELISTED
Monsanto Co
MON
$2.95M 0.36%
26,040
-2,424
-9% -$268K
IDXX icon
84
Idexx Laboratories
IDXX
$46.3B
$2.9M 0.36%
18,743
+163
+0.9% +$22.5K
DIS icon
85
Walt Disney
DIS
$174B
$2.87M 0.35%
25,292
-905
-3% -$99.6K
RTN
86
DELISTED
Raytheon Company
RTN
$2.85M 0.35%
18,711
+1,100
+6% +$166K
AKAM icon
87
Akamai
AKAM
$17.8B
$2.85M 0.35%
47,656
-200
-0.4% -$13.1K
NVS icon
88
Novartis
NVS
$295B
$2.68M 0.33%
40,268
-3,656
-8% -$244K
SHW icon
89
Sherwin-Williams
SHW
$88.6B
$2.64M 0.32%
25,542
-1,110
-4% -$112K
HD icon
90
Home Depot
HD
$350B
$2.61M 0.32%
17,794
+503
+3% +$71.3K
BMY icon
91
Bristol-Myers Squibb
BMY
$131B
$2.51M 0.31%
46,154
-1,125
-2% -$61.7K
APD icon
92
Air Products & Chemicals
APD
$65.8B
$2.43M 0.3%
17,936
+25
+0.1% +$3.52K
IWC icon
93
iShares Micro-Cap ETF
IWC
$1.51B
$2.39M 0.29%
27,953
-992
-3% -$84.3K
AMGN icon
94
Amgen
AMGN
$223B
$2.37M 0.29%
14,450
-500
-3% -$83.1K
FDX icon
95
FedEx
FDX
$73.8B
$2.31M 0.28%
11,819
-130
-1% -$24.8K
T icon
96
AT&T
T
$157B
$2.26M 0.28%
72,039
-1,194
-2% -$37.6K
VXUS icon
97
Vanguard Total International Stock ETF
VXUS
$159B
$2.23M 0.27%
44,965
+8,585
+24% +$415K
VXF icon
98
Vanguard Extended Market ETF
VXF
$31.5B
$2.17M 0.27%
21,693
+1,906
+10% +$189K
WBA
99
DELISTED
Walgreens Boots Alliance
WBA
$2.11M 0.26%
25,445
+1,125
+5% +$94.3K
NEOG icon
100
Neogen
NEOG
$2.55B
$2.11M 0.26%
85,715
-536
-0.6% -$13.1K
2 3
4
5 6

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return

Boston Family Office's Q1 2017 Portfolio in Review

As of Q1 2017, Boston Family Office held 251 positions worth $813M, up 5.6% from $770M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q1 2017 filing shows 10 new, 63 increased, 107 reduced and 7 closed positions. Its largest new stake was Teradyne: 22,100 shares worth $687K. The largest sale was Teva Pharmaceuticals, an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q1 2017 buy was Teradyne: 22,100 shares worth $687K.
  • Boston Family Office added most to Automatic Data Processing in Q1 2017, an estimated $2.9M increase.
  • Boston Family Office's biggest Q1 2017 reduction was Middleby, cutting an estimated $2.44M.
  • Boston Family Office fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $2.64M.
  • Boston Family Office's ten largest holdings make up 21% of its $813M portfolio in Q1 2017.
  • Boston Family Office opened 10 new positions and closed 7 in Q1 2017.
  • Boston Family Office's portfolio value rose 5.6% quarter-over-quarter to $813M.

Based on Boston Family Office's 13F filing for Q1 2017, filed 5 May 2017.